658 results on '"Bonig, Halvard"'
Search Results
52. Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cells
53. Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)
54. CAR T-cells targeting FLT3 have potent activity against FLT3−ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib
55. Donor‐type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors
56. Validation of an ICH Q2 Compliant Flow Cytometry-Based Assay for the Assessment of the Inhibitory Potential of Mesenchymal Stromal Cells on T Cell Proliferation
57. 3109 – IDENTIFICATION OF B LINEAGE COMMITMENT MARKERS FOR GENE EXPRESSION-BASED RISK STRATIFICATION OF INFANT KMT2A::AFF1 ACUTE LYMPHOBLASTIC LEUKEMIA
58. Clinical-scale isolation of the total Aspergillus fumigatus–reactive T–helper cell repertoire for adoptive transfer
59. Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirus
60. RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation
61. Sars-Cov-2 Fails to Infect Mesenchymal Stromal Cells (MSCs) - Pre-Clinical Investigations in Support of Therapeutic Use of MSCs for Severe COVID-19
62. Frequent Whole Blood Donations Select for DNMT3A variants Mediating Enhanced Response to Erythropoietin
63. CD19-CAR-T Cells Are Effective and Safe Treatment of Post-Transplant Relapse in Pediatric and Young Adult Patients with B-Lineage ALL: Real-World Data from Germany
64. Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies
65. Multi-site evaluation of the BD Stem Cell Enumeration Kit for CD34+ cell enumeration on the BD FACSCanto II and BD FACSCalibur flow cytometers
66. HIV-1 Infection of Long-Lived Hematopoietic Precursors In Vitro and In Vivo
67. Co-culture of primary human T cells with leukemia cells to measure regulatory T cell expansion
68. Immunomagnetic selection or irradiation eliminates alloreactive cells but also reduces anti-tumor potential of cytokine-induced killer cells: implications for unmanipulated cytokine-induced killer cell infusion
69. SARS‐CoV‐2‐specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID‐19 vaccination
70. The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia
71. A validation protocol and evaluation algorithms to determine compatibility of cell therapy product matrices in microbiological testing
72. Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma
73. Reversible Streptamer Technology Facilitates the Selection of T Regulatory Cells From Cryopreserved Cord Blood
74. Management of Chronic Graft-vs.-Host Disease in Children and Adolescents With ALL: Present Status and Model for a Personalised Management Plan
75. Current Prophylaxis and Treatment Approaches for Acute Graft-Versus-Host Disease in Haematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukaemia
76. Enumeration of viable CD34+ cells by flow cytometry in blood, bone marrow and cord blood: results of a study of the novel BD™ stem cell enumeration kit
77. Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients
78. Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia
79. Implication of ICOSLG on Relapse in Infant T(4;11) Acute Lymphoblastic Leukemia
80. Dopaminergic Modulation of Cognitive Preparation for Overt Reading: Evidence from the Study of Genetic Polymorphisms
81. Oncostatin M regulates hematopoietic stem cell (HSC) niches in the bone marrow to restrict HSC mobilization
82. Supportive Care During Pediatric Hematopoietic Stem Cell Transplantation: Prevention of Infections. A Report From Workshops on Supportive Care of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)
83. Single Cell Analysis Identifies Expression of PD-L2 on Human Bone Marrow Hematopoietic Stem Cells
84. On the adaptation of endosteal stem cell niche function in response to stress
85. Red blood cell depletion from bone marrow and peripheral blood buffy coat: a comparison of two new and three established technologies
86. Biosimilar granulocyte–colony-stimulating factor for healthy donor stem cell mobilization: need we be afraid?
87. Additional file 1 of Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site
88. Additional file 3 of Generation and validation of a formula to calculate hemoglobin loss on a cohort of healthy adults subjected to controlled blood loss
89. Additional file 2 of Generation and validation of a formula to calculate hemoglobin loss on a cohort of healthy adults subjected to controlled blood loss
90. Epigenetic Modifications and Chromosome Conformations of the Beta Globin Locus throughout Development
91. AXL Inhibition in Macrophages Stimulates Host-versus-Leukemia Immunity and Eradicates Naïve and Treatment-Resistant Leukemia
92. Preanalytic depletion of medicinal anti-CD38 antibody from patient plasma for immunohematology testing
93. Depletion of CD45RA+ T cells: Advantages and disadvantages of different purification methods
94. Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site
95. Absence of the CXCR4 Antagonist EPI-X4 from Pharmaceutical Human Serum Albumin Preparations
96. Granulocyte collections: comparison of two apheresis systems
97. Introduction of principles of blood management to healthy donor bone marrow harvesting
98. ERBB2-CAR-Engineered Cytokine-Induced Killer Cells Exhibit Both CAR-Mediated and Innate Immunity Against High-Risk Rhabdomyosarcoma
99. The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction : the BAMI trial
100. Adaptive Immunity and Pathogenesis of Diabetes: Insights Provided by the α4–Integrin Deficient NOD Mouse
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.